SG11202101905YA - Vitamin d pediatric dosage forms, methods of making and using - Google Patents
Vitamin d pediatric dosage forms, methods of making and usingInfo
- Publication number
- SG11202101905YA SG11202101905YA SG11202101905YA SG11202101905YA SG11202101905YA SG 11202101905Y A SG11202101905Y A SG 11202101905YA SG 11202101905Y A SG11202101905Y A SG 11202101905YA SG 11202101905Y A SG11202101905Y A SG 11202101905YA SG 11202101905Y A SG11202101905Y A SG 11202101905YA
- Authority
- SG
- Singapore
- Prior art keywords
- vitamin
- making
- methods
- dosage forms
- pediatric dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
- A61P5/20—Drugs for disorders of the endocrine system of the parathyroid hormones for decreasing, blocking or antagonising the activity of PTH
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Physiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862725940P | 2018-08-31 | 2018-08-31 | |
PCT/IB2019/057360 WO2020044314A1 (en) | 2018-08-31 | 2019-08-30 | Vitamin d pediatric dosage forms, methods of making and using |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202101905YA true SG11202101905YA (en) | 2021-03-30 |
Family
ID=68165642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202101905YA SG11202101905YA (en) | 2018-08-31 | 2019-08-30 | Vitamin d pediatric dosage forms, methods of making and using |
Country Status (21)
Country | Link |
---|---|
US (3) | US11000480B2 (es) |
EP (1) | EP3843706A1 (es) |
JP (1) | JP2021535155A (es) |
KR (1) | KR20210054539A (es) |
CN (1) | CN112912067A (es) |
AU (4) | AU2019329905B2 (es) |
BR (1) | BR112021003788A2 (es) |
CA (1) | CA3110020A1 (es) |
CL (2) | CL2021000493A1 (es) |
CO (1) | CO2021003805A2 (es) |
CR (1) | CR20210158A (es) |
DE (1) | DE202019005769U1 (es) |
EA (1) | EA202190633A1 (es) |
EC (1) | ECSP21021189A (es) |
IL (1) | IL280937A (es) |
MX (1) | MX2020011740A (es) |
PE (1) | PE20211489A1 (es) |
PH (1) | PH12021550413A1 (es) |
SG (1) | SG11202101905YA (es) |
TW (1) | TW202034905A (es) |
WO (1) | WO2020044314A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021205225A1 (en) | 2020-04-06 | 2021-10-14 | Eirgen Pharma Ltd. | 25-hydroxyvitamin d for the treatment of sars-cov-2 infection |
WO2021245458A1 (en) | 2020-05-31 | 2021-12-09 | Eirgen Pharma Ltd. | Hard capsule dosage form and uses thereof |
US11672761B2 (en) | 2020-11-16 | 2023-06-13 | Orcosa Inc. | Rapidly infusing platform and compositions for therapeutic treatment in humans |
CN114176164A (zh) * | 2021-12-17 | 2022-03-15 | 广东驱动力生物科技股份有限公司 | 反刍动物用水溶性抗应激助剂 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS59155309A (ja) * | 1983-02-22 | 1984-09-04 | Teijin Ltd | 活性型ビタミンd↓3類組成物 |
JP2845342B2 (ja) * | 1990-04-28 | 1999-01-13 | 大正製薬株式会社 | ビタミンd▲下3▼誘導体含有固形製剤組成物 |
JPH04198129A (ja) * | 1990-11-28 | 1992-07-17 | Sumitomo Pharmaceut Co Ltd | 活性型ビタミンd↓3類含有組成物 |
CA2065603C (en) * | 1991-04-09 | 2007-04-03 | Hiroki Itoh | Stabilized vitamin d preparation |
ES2170069T3 (es) * | 1992-06-22 | 2002-08-01 | Bone Care Int Inc | 1-alfa-hidroxiprevitamina d para administracion oral. |
US7632518B2 (en) * | 2002-01-15 | 2009-12-15 | Dsm Ip Assets B.V. | 25-hydroxy vitamin D3 compositions |
SI3095447T1 (sl) * | 2006-02-03 | 2022-02-28 | Opko Renal, Llc | Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3 |
CA2943032C (en) * | 2007-04-25 | 2019-05-07 | Cytochroma Inc. | Oral controlled release compositions comprising vitamin d compound and waxy carrier |
CN101584683A (zh) * | 2009-06-12 | 2009-11-25 | 沈阳药科大学 | 美托拉宗缓释胶囊及其制备方法 |
WO2012047098A1 (en) * | 2010-10-04 | 2012-04-12 | Dishman Pharmaceuticals And Chemicals Ltd. | Encapsulated fat-soluble vitamin |
WO2013105026A1 (en) * | 2012-01-09 | 2013-07-18 | Department Of Biotechnology (Dbt) | A process for preparing solid lipid sustained release nanoparticles for delivery of vitamins |
EP2822542A1 (en) * | 2012-03-07 | 2015-01-14 | Santarus, Inc. | Controlled-release solid dosage forms of mesalamine |
US10751287B2 (en) * | 2013-03-15 | 2020-08-25 | Purdue Pharma L.P. | Tamper resistant pharmaceutical formulations |
KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 d 방출 제형 |
US20160008377A1 (en) * | 2014-07-12 | 2016-01-14 | Aphios Corporation | Formulations and compositions of vitamin d analogs for treating and preventing cancer and other diseases |
PE20170392A1 (es) * | 2014-08-07 | 2017-04-07 | Opko Ireland Global Holdings Ltd | Terapia adjuntiva con 25-hidroxi vitamina d |
WO2017060320A1 (en) * | 2015-10-07 | 2017-04-13 | Dsm Ip Assets B.V. | Multivitamin extrudates |
CN108420797B (zh) * | 2018-05-09 | 2022-05-03 | 南京海融制药有限公司 | 维生素d类似物制剂及其制备方法 |
-
2019
- 2019-08-30 JP JP2021510876A patent/JP2021535155A/ja active Pending
- 2019-08-30 CR CR20210158A patent/CR20210158A/es unknown
- 2019-08-30 EA EA202190633A patent/EA202190633A1/ru unknown
- 2019-08-30 CN CN201980064183.4A patent/CN112912067A/zh active Pending
- 2019-08-30 SG SG11202101905YA patent/SG11202101905YA/en unknown
- 2019-08-30 MX MX2020011740A patent/MX2020011740A/es unknown
- 2019-08-30 PE PE2021000260A patent/PE20211489A1/es unknown
- 2019-08-30 TW TW108131446A patent/TW202034905A/zh unknown
- 2019-08-30 CA CA3110020A patent/CA3110020A1/en active Pending
- 2019-08-30 BR BR112021003788-8A patent/BR112021003788A2/pt unknown
- 2019-08-30 WO PCT/IB2019/057360 patent/WO2020044314A1/en active Application Filing
- 2019-08-30 KR KR1020217009143A patent/KR20210054539A/ko active Search and Examination
- 2019-08-30 AU AU2019329905A patent/AU2019329905B2/en active Active
- 2019-08-30 DE DE202019005769.2U patent/DE202019005769U1/de active Active
- 2019-08-30 EP EP19783665.3A patent/EP3843706A1/en active Pending
-
2020
- 2020-05-07 US US16/869,273 patent/US11000480B2/en active Active
-
2021
- 2021-02-17 IL IL280937A patent/IL280937A/en unknown
- 2021-02-26 CL CL2021000493A patent/CL2021000493A1/es unknown
- 2021-02-26 PH PH12021550413A patent/PH12021550413A1/en unknown
- 2021-03-25 CO CONC2021/0003805A patent/CO2021003805A2/es unknown
- 2021-03-26 EC ECSENADI202121189A patent/ECSP21021189A/es unknown
- 2021-04-07 US US17/224,768 patent/US20210401752A1/en active Pending
- 2021-08-25 AU AU2021107168A patent/AU2021107168A4/en active Active
- 2021-08-25 AU AU2021107174A patent/AU2021107174A4/en active Active
- 2021-09-17 US US17/478,395 patent/US20220000783A1/en active Pending
-
2023
- 2023-08-28 CL CL2023002539A patent/CL2023002539A1/es unknown
-
2024
- 2024-05-01 AU AU2024202877A patent/AU2024202877A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
BR112021003788A2 (pt) | 2021-06-08 |
PE20211489A1 (es) | 2021-08-11 |
KR20210054539A (ko) | 2021-05-13 |
IL280937A (en) | 2021-04-29 |
CO2021003805A2 (es) | 2021-04-19 |
AU2019329905B2 (en) | 2024-02-01 |
TW202034905A (zh) | 2020-10-01 |
CL2021000493A1 (es) | 2021-07-23 |
CN112912067A (zh) | 2021-06-04 |
WO2020044314A1 (en) | 2020-03-05 |
EP3843706A1 (en) | 2021-07-07 |
US20220000783A1 (en) | 2022-01-06 |
US20210401752A1 (en) | 2021-12-30 |
CR20210158A (es) | 2021-05-21 |
MX2020011740A (es) | 2021-04-19 |
DE202019005769U1 (de) | 2022-01-13 |
ECSP21021189A (es) | 2021-04-29 |
US11000480B2 (en) | 2021-05-11 |
AU2019329905A1 (en) | 2021-03-18 |
JP2021535155A (ja) | 2021-12-16 |
US20200338006A1 (en) | 2020-10-29 |
AU2024202877A1 (en) | 2024-05-23 |
PH12021550413A1 (en) | 2021-09-27 |
AU2021107168A4 (en) | 2021-12-09 |
AU2021107174A4 (en) | 2021-12-09 |
EA202190633A1 (ru) | 2021-07-12 |
CL2023002539A1 (es) | 2024-02-23 |
CA3110020A1 (en) | 2020-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL273706A (en) | Liquid dosage forms, methods of preparation and uses | |
HUE054964T2 (hu) | Pirazol-heteroaril készítmény, az elõállítás módja és gyógyászati felhasználása | |
EP3681479A4 (en) | METHOD OF ADMINISTRATION AND TREATMENT | |
IL259711A (en) | Methods for the preparation of protein kinase inhibitors and their medical use | |
IL280937A (en) | Dosage forms of vitamin D intended for children, methods of their preparation and use | |
PT3486242T (pt) | Derivado de oxopicolinamida, método de preparação para esse fim e utilização farmacêutica do mesmo | |
GB201817116D0 (en) | Pharmaceutical preparation of palbociclic and preparation method thereof | |
HK1254644A1 (zh) | 用於藥品給藥和混合及其恰當技術訓練的裝置和方法 | |
SI3487505T1 (sl) | Dajanje in odmerek diaminofenotiazinov | |
IL272446A (en) | Penta-condensed hexa-heterocyclic compounds, method for their preparation, drug combination and use thereof | |
EP3349599A4 (en) | INHIBITABLE NICOTINE FORMULATIONS AND PROCESS FOR THE PREPARATION AND USE THEREOF | |
EP3307381A4 (en) | MULTIVECTOR PATIENT ELECTRODES SYSTEM AND METHOD OF USE | |
EP3347348A4 (en) | PREPARATION OF 3-HYDROXY-3,6-DIMETHYLHEXAHYDROBENZOFURAN-2-ON AND DERIVATIVES THEREOF | |
EP3653202A4 (en) | PHARMACEUTICAL PREPARATION AND MANUFACTURING PROCESSES FOR IT | |
EP3115377A4 (en) | Mutant antibody of full human her2 antibody, coding gene and use thereof | |
ZA201906326B (en) | Analogs of deutetrabenazine, their preparation and use | |
HK1223630A1 (zh) | 抗- 療法的實施與用量 | |
GB201812324D0 (en) | Near-infraed chromophores, process of preparation and methods of use | |
EP3437681A4 (en) | DEVICE FOR THE ADMINISTRATION OF MEDICAMENT METHODS FOR THE ADMINISTRATION OF MEDICAMENTS AND METHOD FOR THE PRODUCTION OF A DEVICE FOR ADMINISTERING MEDICAMENTS | |
EP3425388A4 (en) | METHOD OF EVALUATING PAIN CAUSED BY ADMINISTRATION OF DRUG SOLUTION, METHOD OF SELECTING DRUG SOLUTION DELIVERY | |
IL271727A (en) | Method of treatment and their dosage forms | |
IL291196A (en) | Standards and methods for determining the dose of the drug | |
EP3664831A4 (en) | ANTI-NEURODENERENCE THERAPEUTIC COMPOUND, METHOD OF MANUFACTURE AND USE | |
GB201710382D0 (en) | Administration and dosage of Diaminophenothiazines | |
HK1259196A1 (zh) | 延遲釋放製劑、其製備方法和用途 |